PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...

State police are providing new details on the allegations against the executive director of the Greater Altoona Career and ...

In a report released today, Gena Wang from Barclays maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a price target of $45.00. The company’s shares closed yesterday at ...

Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...

This is the first gene therapy for AADC deficiency to receive US regulatory approval and the first that can be administered directly to the brain.

The approval marks the first time gene therapy will be available to treat patients with aromatic I-amino acid decarboxylase ...

PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...

PTC Industries and more will announce their results for September 2024 quarter later today. Corporate actions today: Shares ...

The National Hurricane Center is monitoring Potential Tropical Cyclone 19, which could impact Florida sometime next week | ...

Police say this year alone, they've investigated cases where seniors lost more than $800,000 and more than $1,000,000 to ...

"I don't want to live my life in bed," she said ... covering everything from pandemics to the rise of obesity worldwide.

In a separate news release, PTC executives said launch preparations are under way, with centers of excellence already ...